drugset / Trial / NCT02237287
Combination of Taliderm® and Vacuum-assisted Closure (VAC) for Treatment of Pressure Ulcers
Phase 0
Terminated
24 enrolled
University Hospital, Basel, Switzerland
Marine Polymer Technologies, Inc. · collab
RandomizedFactorialQuadruple-blindTreatment
Summary
Background: The wound healing promoting effect of negative wound pressure therapies (NWPT) takes place at the wound foam interface. Implementation of bioactive substances at this site represents a major research area for the development of future NWPT devices. Methods: Wound healing kinetics of pressure ulcers treated by vacuum assisted closure devices with or without the implementation of a thin interface of poly-N-acetyl glucosamine nanofibers (sNAG) was studied in a prospective randomized clinical trial.
Timeline
- Start
- 2011-02
- Primary completion
- 2012-08
- Completion
- 2012-08
Outcome
Outcome not reported
Stopped: “Open label study part reduced from n=10 to n=6 because of insufficient number of patients under antiaggregation.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | poly-N-acetyl glucosamine nanofibers | Unknown | — | — |